NASDAQ:CRNX

Crinetics Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy CRNX

*Your capital is at risk

$33.09

+0.480 (+1.47%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CRNX Prediction Chart

CRNX Predictions History

Latest community submissions for CRNX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
ReginaMIlls132085	Jan 2, 2020	Bearish	$25.40	X	—	0
PHILLIPWELLS132027	Jan 2, 2020	Bearish	$25.40	X	—	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CRNX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CRINETICS PHARMACEUTICALS INC

Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III clinical trial for the treatment of acromegaly, as well as completed phase II clinical trial to treat c...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by